Cullinan Therapeutics Logo

Cullinan Therapeutics

🇺🇸
CGEM
US2300311063

Cullinan Therapeutics is a US-based biopharmaceutical company specializing in the development of innovative cancer therapies. Through a diverse pipeline approach, Cullinan focuses on precision oncology solutions to improve treatment outcomes for patients.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will Cullinan Therapeutics report its next quarterly earnings?

Cullinan Therapeutics is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Cullinan Therapeutics last report quarterly earnings?

Cullinan Therapeutics last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.81 USD.

How often has Cullinan Therapeutics beaten expectations?

Cullinan Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Cullinan Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.85
Actual:
Q2 2026
Missed
Estimate:-$0.80
Actual:-$0.81
Difference:-$0.01
Price reaction (1 day):+1.9 %
Price reaction (7 days):+11.5 %
Q1 2026
Beat
Estimate:-$0.84
Actual:-$0.75
Difference:+$0.09
Price reaction (1 day):-1.8 %
Price reaction (7 days):+7.7 %
Q3 2025
Beat
Estimate:-$0.84
Actual:-$0.77
Difference:+$0.07
Q2 2025
Beat
Estimate:-$0.89
Actual:-$0.77
Difference:+$0.12
Q1 2025
Missed
Estimate:-$0.86
Actual:-$1.07
Difference:-$0.21

Earnings statistics

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
+1.8%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Cullinan Therapeutics
Ticker Symbol
CGEM
ISIN
US2300311063
Country
🇺🇸
USA
Sector